Portal vein embolization combined with ex vivo liver resection and autotransplantation: A novel treatment strategy for end-stage and metastatic hepatic alveolar echinococcosis  

作　　者：Qiang Guo Mao-Lin Wang Kai Zhong Jia-Long Li Tie-Min Jiang Hao Wen Tuerganaili Aji Ying-Mei Shao 

机构地区：[1]Department of Hepatobiliary and Echinococcosis Surgery,Digestive and Vascular Surgery Center,First Affiliated Hospital of Xinjiang Medical University,Urumqi 830054,China [2]Clinical Medical Research Center of Echinococcosis and Hepatobiliary Disease of Xinjiang Uygur Autonomous Region,Urumqi 830054,China [3]State Key Laboratory of Pathogenesis,Prevention and Treatment of High Incidence Diseases in Central Asia,Xinjiang Medical University,Urumqi 830054,China

出　　处：《Hepatobiliary & Pancreatic Diseases International》2024年第2期210-216,共7页国际肝胆胰疾病杂志（英文版）

基　　金：This study was supported by the grants from the National Natural Science Foundation of China(81960377);Open Project of State Key Laboratory of Pathogenesis,Prevention and Treatment of High Incidence Diseases in Central Asia(SKL-HIDCA-2020-BC and SKL-HIDCA-2021-4);Xinjiang Uygur Autonomous Region University Scientific Research Project(XJEDU2021I016).

摘　　要：Alveolar echinococcosis(AE)is a lethal parasitic disease caused by Echinococcus multilocularis larvae,and more than 90%of pri-mary AE lesions occur in the liver.Most of the affected individ-uals remain asymptomatic and the disease is often diagnosed at an advanced stage.The infection may spread to organs adjacent to the liver or distant locations,eventually causing end-stage multi-ple organ AE.Brain metastasis of AE is the most fatal with an inci-dence rate of 0.2%[1].

关 键 词：ORGANS ECHINOCOCCOSIS METASTASIS 

分 类 号：R657.3[医药卫生—外科学]